← ANALYST RATINGS · TIPRANKS
AdaptHealth (AHCO): analyst forecast and price target
Analyst consensus
Strong Buy6 Buy0 Hold0 Sell
Ratings of 6 analysts in the last 3 months12-month forecast
Based on 6 price targets given in the last 3 months, the average target is $9.40, the highest $10.00, the lowest $8.00. The average is +56.1% from the last price of $6.02.
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $6.00 → $6.50+8.3% | Hold | +8.0% | Reiterated | 16.10.26on TipRanks 10:05 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $6.00 → $6.50+8.3% | Hold | +8.0% | Reiterated | 16.10.26on TipRanks 10:05 | — | |
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $6.00 → $6.50+8.3% | Hold | +8.0% | Reiterated | 14.10.26on TipRanks 07:05 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $6.00 → $6.50+8.3% | Hold | +8.0% | Reiterated | 14.10.26on TipRanks 07:05 | — | |
| Eric Coldwell★★★★★★★★★★#1091 · hits 59% · avg +7.7% | Robert W. Baird | $10.00 → $9.00−10.0% | Buy | +49.5% | Reiterated | 17.09.26on TipRanks 07:20 | −3.7%next day −1.0% · 5 days −4.1% | ↗ |
| Brian Tanquilut★★★★★★★★★★#1681 · hits 52% · avg +6.6% | Jefferies | $10.00 | Buy | +66.1% | Reiterated | 15.09.26on TipRanks 10:45 | −0.6%next day +2.0% · 5 days −3.2% | ↗ |
| David S Macdonald★★★★★★★★★★#400 · hits 63% · avg +13.2% | Truist Financial | — | Buy | — | Reiterated | 09.09.26on TipRanks 08:45 | −7.5%next day +3.2% · 5 days +4.8% | ↗ |
| Richard Close★★★★★★★★★★#1081 · hits 49% · avg +10.0% | Canaccord Genuity | $10.00 | Buy | +66.1% | Reiterated | 09.09.26on TipRanks 07:30 | −7.5%next day +3.2% · 5 days +4.8% | ↗ |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $6.00 | Hold | −0.3% | Reiterated | 09.09.26on TipRanks 01:05 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $5.50 → $6.00+9.1% | Hold | −0.3% | Reiterated | 09.09.26on TipRanks 01:05 | — | |
| Kevin Caliendo★★★★★★★★★★#2646 · hits 56% · avg +5.6% | UBS | $10.00 | Buy | +66.1% | Assigned | 24.08.26on TipRanks 08:35 | +0.3%next day −3.0% · 5 days −1.2% | ↗ |
| Ben Hendrix★★★★★★★★★★#1571 · hits 53% · avg +7.2% | RBC Capital | $15.00 → $8.00−46.7% | Buy | +32.9% | Assigned | 05.08.26on TipRanks Aug 6 06:50 | −3.0%next day −6.8% · 5 days −11.5% | ↗ |
| Pito Chickering★★★★★★★★★★#1500 · hits 61% · avg +9.8% | Deutsche Bank | $10.50 → $9.50−9.5% | Hold | +57.8% | Reiterated | 25.02.26on TipRanks 08:40 | +4.5%next day −2.1% · 5 days +4.8% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering AdaptHealth
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $9.40 at a price of $5.64 (+66.7%); now: $9.40 at $6.02 (+56.1%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 7 | 9 | 9 |
| Buy | 5 | 6 | 9 | 7 | 7 | 3 |
| Hold | 1 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 10.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $-0.05 (from $-0.15 to $0.12). Last quarter: $0.16.
Sales
Next quarter’s sales estimate — $726M (from $722M to $730M). Last quarter: $740M.
Best top-analyst consensus in the sector · Healthcare
About AdaptHealth
- CEO: Suzanne Foster
- Employees: 10,900
- 555 East North Lane, Conshohocken, PA, 19428, US
- adapthealth.com
AdaptHealth Corp., alongside its network of subsidiaries, delivers a comprehensive range of home medical equipment (HME), supplies, and associated services across the United States. The company specializes in sleep therapy, providing CPAP and bi-PAP devices and support for individuals managing obstructive sleep apnea. It also furnishes essential medical devices and provisions for diabetes treatment, such as continuous glucose monitors and insulin pumps. AdaptHealth supplies HME to patients transitioning from acute care settings, offers in-home oxygen and chronic therapy services, and caters to chronically ill patients with specialized equipment and supplies for wound care, urological, incontinence, ostomy, and nutritional needs. These services are accessible to beneficiaries of Medicare, Medicaid, and various commercial insurance payors. AdaptHealth Corp. is primarily based in Plymouth Meeting, Pennsylvania.
Data from the stock’s TipRanks forecast page, read 12 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗